Baxter International Financial Statements (BAX)
|
|
|
|
Report date
|
|
|
23.02.2022 |
09.02.2023 |
08.02.2024 |
21.02.2025 |
12.02.2026 |
|
30.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
12 146 |
10 057 |
10 360 |
10 636 |
11 244 |
|
11 320 |
|
Operating Income, bln rub |
|
|
1 350 |
-2 845 |
707.0 |
14.0 |
-308.0 |
|
-300.0 |
|
EBITDA, bln rub |
? |
|
2 190 |
-1 763 |
1 734 |
1 116 |
766.0 |
|
744.0 |
|
Net profit, bln rub |
? |
|
1 284 |
-2 433 |
2 656 |
-649.0 |
-957.0 |
|
-1 098 |
|
|
OCF, bln rub |
? |
|
2 222 |
1 211 |
1 726 |
1 019 |
845.0 |
|
1 251 |
|
CAPEX, bln rub |
? |
|
691.0 |
635.0 |
436.0 |
460.0 |
522.0 |
|
537.0 |
|
FCF, bln rub |
? |
|
1 531 |
576.0 |
1 290 |
559.0 |
323.0 |
|
714.0 |
|
Dividend payout, bln rub
|
|
|
530.0 |
573.0 |
586.0 |
590.0 |
348.0 |
|
266.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
41.3% |
0.00% |
22.1% |
0.00% |
0.00% |
|
-24.2% |
|
|
OPEX, bln rub |
|
|
3 370 |
6 394 |
3 443 |
3 970 |
3 687 |
|
3 709 |
|
Cost of production, bln rub |
|
|
7 426 |
6 508 |
6 210 |
6 652 |
7 865 |
|
7 911 |
|
R&D, bln rub |
|
|
531.0 |
450.0 |
518.0 |
590.0 |
518.0 |
|
517.0 |
|
Interest expenses, bln rub |
|
|
207.0 |
413.0 |
508.0 |
408.0 |
290.0 |
|
275.0 |
|
|
Assets, bln rub |
|
|
33 521 |
28 287 |
28 276 |
25 782 |
20 055 |
|
19 846 |
|
Net Assets, bln rub |
? |
|
9 077 |
5 833 |
8 402 |
6 964 |
6 129 |
|
6 043 |
|
Debt, bln rub |
|
|
18 310 |
17 203 |
14 113 |
13 449 |
10 003 |
|
9 687 |
|
Cash, bln rub |
|
|
2 951 |
1 718 |
3 078 |
1 764 |
1 966 |
|
2 017 |
|
Net debt, bln rub |
|
|
15 359 |
15 485 |
11 035 |
11 685 |
8 037 |
|
7 670 |
|
|
Ordinary share price, rub |
|
|
85.8 |
51.0 |
38.7 |
29.2 |
19.1 |
|
17.5 |
|
Number of ordinary shares, mln |
|
|
502.0 |
504.0 |
506.0 |
510.0 |
513.0 |
|
515.0 |
|
|
Market cap, bln rub |
|
|
43 092 |
25 689 |
19 562 |
14 872 |
9 803 |
|
9 031 |
|
EV, bln rub |
? |
|
58 451 |
41 174 |
30 597 |
26 557 |
17 840 |
|
16 701 |
|
Book value, bln rub |
|
|
-8 551 |
-7 412 |
-3 309 |
-3 534 |
-3 169 |
|
-3 074 |
|
|
EPS, rub |
? |
|
2.56 |
-4.83 |
5.25 |
-1.27 |
-1.87 |
|
-2.13 |
|
FCF/share, rub |
|
|
3.05 |
1.14 |
2.55 |
1.10 |
0.63 |
|
1.39 |
|
BV/share, rub |
|
|
-17.0 |
-14.7 |
-6.54 |
-6.93 |
-6.18 |
|
-5.97 |
|
|
EBITDA margin, % |
? |
|
18.0% |
-17.5% |
16.7% |
10.5% |
6.81% |
|
6.57% |
|
Net margin, % |
? |
|
10.6% |
-24.2% |
25.6% |
-6.10% |
-8.51% |
|
-9.70% |
|
FCF yield, % |
? |
|
3.55% |
2.24% |
6.59% |
3.76% |
3.29% |
|
7.91% |
|
ROE, % |
? |
|
14.1% |
-41.7% |
31.6% |
-9.32% |
-15.6% |
|
-18.2% |
|
ROA, % |
? |
|
3.83% |
-8.60% |
9.39% |
-2.52% |
-4.77% |
|
-5.53% |
|
|
P/E |
? |
|
33.6 |
-10.6 |
7.37 |
-22.9 |
-10.2 |
|
-8.22 |
|
P/FCF |
|
|
28.1 |
44.6 |
15.2 |
26.6 |
30.4 |
|
12.6 |
|
P/S |
? |
|
3.55 |
2.55 |
1.89 |
1.40 |
0.87 |
|
0.80 |
|
P/BV |
? |
|
-5.04 |
-3.47 |
-5.91 |
-4.21 |
-3.09 |
|
-2.94 |
|
EV/EBITDA |
? |
|
26.7 |
-23.4 |
17.6 |
23.8 |
23.3 |
|
22.4 |
|
Debt/EBITDA |
|
|
7.01 |
-8.78 |
6.36 |
10.5 |
10.5 |
|
10.3 |
|
|
R&D/CAPEX, % |
|
|
76.8% |
70.9% |
118.8% |
128.3% |
99.2% |
|
96.3% |
|
|
CAPEX/Revenue, % |
|
|
5.69% |
6.31% |
4.21% |
4.32% |
4.64% |
|
4.74% |
|
| Baxter International shareholders |
